JP2017534571A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017534571A5 JP2017534571A5 JP2017511183A JP2017511183A JP2017534571A5 JP 2017534571 A5 JP2017534571 A5 JP 2017534571A5 JP 2017511183 A JP2017511183 A JP 2017511183A JP 2017511183 A JP2017511183 A JP 2017511183A JP 2017534571 A5 JP2017534571 A5 JP 2017534571A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- chain variable
- antigen
- binding molecule
- variable domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462043228P | 2014-08-28 | 2014-08-28 | |
| US62/043,228 | 2014-08-28 | ||
| PCT/US2015/047174 WO2016033321A1 (en) | 2014-08-28 | 2015-08-27 | Multivalent fragments of antibody 3e10 and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019217791A Division JP2020040987A (ja) | 2014-08-28 | 2019-12-02 | 抗体3e10の多価フラグメントおよびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017534571A JP2017534571A (ja) | 2017-11-24 |
| JP2017534571A5 true JP2017534571A5 (cg-RX-API-DMAC7.html) | 2018-10-04 |
Family
ID=54064606
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017511183A Withdrawn JP2017534571A (ja) | 2014-08-28 | 2015-08-27 | 抗体3e10の多価フラグメントおよびその使用方法 |
| JP2019217791A Withdrawn JP2020040987A (ja) | 2014-08-28 | 2019-12-02 | 抗体3e10の多価フラグメントおよびその使用方法 |
| JP2022001621A Pending JP2022037244A (ja) | 2014-08-28 | 2022-01-07 | 抗体3e10の多価フラグメントおよびその使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019217791A Withdrawn JP2020040987A (ja) | 2014-08-28 | 2019-12-02 | 抗体3e10の多価フラグメントおよびその使用方法 |
| JP2022001621A Pending JP2022037244A (ja) | 2014-08-28 | 2022-01-07 | 抗体3e10の多価フラグメントおよびその使用方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20170291961A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3194450A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2017534571A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016033321A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6178785B2 (ja) | 2011-04-01 | 2017-08-09 | イェール ユニバーシティーYale University | 細胞浸透性抗dna抗体およびdna修復を阻害するためのその使用 |
| WO2015134607A1 (en) | 2014-03-04 | 2015-09-11 | Yale University | Cell penetrating anti-guanosine antibody based therapy for cancers with ras mutations |
| US10238742B2 (en) | 2014-06-25 | 2019-03-26 | Yale University | Cell penetrating nucleolytic antibody based cancer therapy |
| US12486318B2 (en) | 2016-06-15 | 2025-12-02 | Yale University | Anti-guanosine antibody as a molecular delivery vehicle |
| EP3471777A1 (en) * | 2016-06-15 | 2019-04-24 | Yale University | Antibody-mediated autocatalytic, targeted delivery of nanocarriers to tumors |
| US11613590B2 (en) * | 2017-07-17 | 2023-03-28 | Nucleus Therapeutics Pty. Ltd | Binding proteins 1 |
| US20210137960A1 (en) | 2018-02-01 | 2021-05-13 | Yale University | Compositions and methods for inhibition of nuclear-penetrating antibodies |
| US12304970B2 (en) | 2018-02-01 | 2025-05-20 | Yale University | Nuclear localization signals, compositions formed therefrom, and methods of use thereof for delivery of cargo to the nucleus |
| EP3844287B1 (en) | 2018-08-31 | 2024-05-22 | Yale University | Compositions and methods for enhancing donor oligonucleotide-based gene editing |
| BR112021003823A2 (pt) * | 2018-08-31 | 2021-05-25 | Yale University | composição, composição farmacêutica e método para modificar o genoma de uma célula |
| US20210340279A1 (en) * | 2018-08-31 | 2021-11-04 | Yale University | Compositions and methods of using cell-penetrating antibodies in combination with immune checkpoint modulators |
| KR20220101073A (ko) | 2019-08-30 | 2022-07-19 | 예일 유니버시티 | 핵산을 세포로 전달하기 위한 조성물 및 방법 |
| WO2021077070A1 (en) | 2019-10-18 | 2021-04-22 | Yale University | Compositions and methods for inhibition of cell-penetrating antibodies |
| WO2022047424A1 (en) | 2020-08-31 | 2022-03-03 | Yale University | Compositions and methods for delivery of nucleic acids to cells |
| AU2023228912A1 (en) | 2022-03-03 | 2024-09-19 | Yale University | Humanized 3e10 antibodies, variants, and antigen binding fragments thereof |
| EP4584292A1 (en) | 2022-09-09 | 2025-07-16 | Yale University | Proteolysis targeting antibodies and methods of use thereof |
| WO2024140936A1 (en) * | 2022-12-30 | 2024-07-04 | Cstone Pharmaceuticals (Suzhou) Co., Ltd. | Humanized cell-penetrating antibodies |
| WO2026039779A1 (en) | 2024-08-15 | 2026-02-19 | Yale University | Humanized 3e10 antibodies and antigen binding fragments optimized for rad51 binding |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4812397A (en) | 1987-02-10 | 1989-03-14 | The Regents Of The University Of California | MAB-anti-DNA related to nephritis |
| WO1997032602A1 (en) * | 1996-03-08 | 1997-09-12 | The Regents Of The University Of California | DELIVERY SYSTEM USING mAb 3E10 AND MUTANTS AND/OR FUNCTIONAL FRAGMENTS THEREOF |
| WO2012145125A1 (en) * | 2011-03-25 | 2012-10-26 | 4S3 Bioscience Inc. | Targeted radionuclides |
| JP6178785B2 (ja) * | 2011-04-01 | 2017-08-09 | イェール ユニバーシティーYale University | 細胞浸透性抗dna抗体およびdna修復を阻害するためのその使用 |
| US9283272B2 (en) * | 2012-03-30 | 2016-03-15 | The United States Of America As Represented By The Department Of Veterans Affairs | Targeting intracellular target-binding determinants with intracellular antibodies |
-
2015
- 2015-08-27 JP JP2017511183A patent/JP2017534571A/ja not_active Withdrawn
- 2015-08-27 EP EP15760023.0A patent/EP3194450A1/en not_active Withdrawn
- 2015-08-27 US US15/507,324 patent/US20170291961A1/en not_active Abandoned
- 2015-08-27 WO PCT/US2015/047174 patent/WO2016033321A1/en not_active Ceased
-
2019
- 2019-11-06 US US16/676,076 patent/US20200199255A1/en not_active Abandoned
- 2019-12-02 JP JP2019217791A patent/JP2020040987A/ja not_active Withdrawn
-
2022
- 2022-01-07 JP JP2022001621A patent/JP2022037244A/ja active Pending